Related Experiment Video
Updated: Oct 1, 2026
Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
Published on: February 22, 2017
Integration of statistical theory and practical clinical expertise. Polymerase chain reaction testing of the
1Duke University Medical Center, Department of Pediatrics, Duke Clinical Research Institute, Durham, NC, USA. danny.benjamin@duke.edu
Insights
Accurate diagnosis of infants exposed to human immunodeficiency virus (HIV) is now possible with polymerase chain reaction (PCR) testing. This testing strategy helps determine infant risk and guides diagnostic algorithms, reducing the need for serologic follow-up.
Area of Science:
- Pediatrics
- Virology
- Infectious Diseases
Background:
- Infant testing for human immunodeficiency virus (HIV) has significantly advanced.
- Polymerase chain reaction (PCR) enables accurate diagnosis by 4 months of age.
- Improved PCR sensitivity and specificity minimize the need for serologic follow-up.
Purpose of the Study:
- To present a rational algorithm for diagnosing HIV-exposed infants using PCR testing.
- To guide clinicians in risk-stratifying infants and selecting appropriate diagnostic pathways.
- To optimize HIV diagnosis in infants through evidence-based testing protocols.
Main Methods:
- Risk stratification of infants based on maternal factors (HAART, viral load) and infant feeding practices.
- Implementation of a tiered PCR testing schedule (2 or 3 tests) based on risk level.
- Inclusion of serologic follow-up for high-risk infants and confirmation of positive PCR results.
Main Results:
- Low-risk infants (maternal HAART, undetectable viral load, no breastfeeding) require 2 PCR tests at 1 and 4 months.
- Moderate-risk infants (unknown/high viral load, no breastfeeding) need 3 negative PCR tests at specified intervals.
- High-risk infants (breastfeeding) require at least 3 negative PCR tests, ongoing testing during breastfeeding, and serologic follow-up.
Conclusions:
- A risk-stratified PCR testing algorithm provides accurate and efficient diagnosis for HIV-exposed infants.
- This approach simplifies diagnostic procedures and reduces reliance on traditional serologic methods.
- Effective management of HIV-exposed infants relies on tailored testing strategies informed by maternal and infant factors.
Abstract:
Testing of the human immunodeficiency virus (HIV)-exposed infant has improved markedly over the past decade. Polymerase chain reaction (PCR) technology has made accurate diagnosis possible by 4 months of age and improved sensitivity and specificity of PCR testing has obviated the need for serologic follow-up for most HIV-exposed infants. Clinicians may use PCR testing and simple statistical theory to develop a rational algorithm for diagnosis of HIV-exposed infants. Physicians should determine whether the infant is at low, moderate, or high risk for acquiring HIV. After risk-stratification the physician may proceed with 2 PCR tests, 3 PCR tests, or PCR testing and serologic follow-up. Infants of mothers who are on highly active antiretroviral therapy (HAART) at delivery, whose mothers have a low or undetectable viral load at delivery, and who do not breast-feed, should be considered low-risk. These low-risk infants should have 2 PCR tests, 1- and 4-months post partum. Infants whose mothers have an unknown or high viral load at delivery and who do not breast-feed should be considered moderate-risk. These infants should have 3 negative PCR tests, 1 during the first month of life, 1 after the first month of life, and 1 after 4 months of life. Infants who breast-feed should be considered high-risk and require at least 3 negative PCR tests, PCR testing every 3 months until breast-feeding stops, and serologic follow-up. Any positive PCR test requires virologic confirmation and serologic follow-up.
More Related Videos
08:37Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
